Cannabis Is An ‘Effective Treatment' For Chronic Pain, Study Finds
The use of medical cannabis is an 'effective treatment option' for chronic pain patients, according to the findings of a recent study. The research also found that chronic pain patients who used cannabis for at least on year 'exhibited significantly lower healthcare utilization' than non-users and had better quality of life.
The study, which was published last week in the journal Pharmacy, was written by researchers with the Florida-based medical cannabis telehealth company Leafwell and George Mason University in Virginia. The findings also showed that chronic pain patients who used cannabis reported fewer visits to urgent care centers and hospital emergency departments (EDs).
Additionally, the data showed that hospitalization rates were lower among chronic pain patients who used medical marijuana, although the difference was not sufficient to be considered statistically significant.
'Exposure [to cannabis] was associated with a 2.0 percentage point reduction in urgent care visits, a 3.2 percentage point reduction in ED visits and fewer unhealthy days per month,' according to a report from online cannabis news source Marijuana Moment.
'The findings of this study suggest, in line with existing research, that medical cannabis is likely an effective treatment option for patients with chronic pain,' authors wrote. 'This underscores the potential for not only [quality of life]
The self-reported data used for the study was collected from chronic pain patients by Leafwell. The telehealth platform operates in 36 states, connecting physicians with patients seeking certification to use medical cannabis.
'The cannabis-exposed group included individuals who had used medical cannabis within the prior year and were seeking recertification of their medical card through Leafwell,' the authors wrote, 'while the unexposed group comprised first-time Leafwell patients who self-reported no cannabis use in the past year.'
Study Of More Than 5,000 Chronic Pain Patients
The study included data from 5,242 chronic pain patients. Of them, 3,943 reported using cannabis over the past year, while the remaining 1,299 participants reported no past-year cannabis use.
Mitchell Doucette, senior research director at Leafwell and the lead author of the study, said the findings show that medical cannabis can improve the lives of chronic pain patients.
'We looked at a large set of real-world data, where we compared medical cannabis users who we knew used for at least one year and people who had never used cannabis,' Doucette told Marijuana Moment. 'When we compared those groups, we found that medical cannabis users who had used for at least one year had lower rates of emergency room visits, lower rates of urgent care visits and, importantly, increased quality of life.'
'When we combine those outcomes,' added Doucette, who has a doctorate in health and public policy from Johns Hopkins, 'it suggests that medical cannabis is not only leading to better quality of life for chronic pain patients but, again, potentially better health outcomes.'
Doucette noted that some previous studies have explored quality-of-life improvements among medical cannabis patients, and other research has studied healthcare outcomes, 'but really this is the first study to kind of connect these two dots.'
Overall, Doucette said, it is becoming increasingly apparent that medical marijuana 'is a helpful medicinal product for certain groups of people' and that healthcare systems 'should try to alleviate access and cost margins for those individuals who it may be too costly of a product for them to access.'
Cannabis And Chronic Pain
The Leafwell study is consistent with other research into the use of medical cannabis as a treatment for chronic pain. Also last week, the National Organization for the Reform of Marijuana Laws (NORML) reported on the results of German study showing that cannabis extracts significantly reduced pain and improved mental health for chronic pain patients who used it.
'Our findings indicate that treatment with medicinal cannabis improves both physical and mental health in patients with chronic pain,' the study's authors concluded. 'The results suggest that medicinal cannabis might be a safe alternative for patients who are inadequately treated with conventional therapies.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
EXCLUSIVE: This Wearable Wellness Clothing Brand Offers Daily Lymphatic Drainage With Onesies, Bras, Leggings and More
Lymphatic drainage just got easier. On Thursday, Cean, a functional clothing brand focused on lymphatic drainage, is launching direct-to-consumer. The brand, coined as 'wearable wellness,' was founded by Lauren Dovey, also the founder of wellness tech brand Heat Healer, which is known for its sauna blanket. More from WWD The Best Nordstrom Anniversary Sale 2025 Fashion Deals Our Shopping Editors Are Buying for Fall and Rouje Collaborate on the Ultimate Parisian Meets New Yorker Collection The Best Polo Shirts for Men to Wear This Summer, Tested by an Editor Cean's initial lineup, which features compression and micromassage for lymphatic drainage, includes a Lymphatic romper, $168; Lymphatic leggings, $138; Lymphatic onesie, $198; Lymphatic sports bra, $58; Lymphatic biker shorts, $78; Lymphatic triangle bralette, $48; Lymphatic long-sleeve top, $98; Lymphatic duo band (which can be worn as a headband or around the face to sculpt the jaw line), $28, and De-Bloat brief underwear, $38, which Dovey said are a first-to-market product. All products are available in six colors: black, nude, cloud, royal navy, retro red and sky blue. According to the brand, these products could sculpt the body, support circulation, eliminate fluid retention, remove toxins, reduce bloating, support recovery, particularly after a workout, and promote healthier-looking skin. Cean's launch follows the success of Heat Healer's wearable wellness collection, which launched in July 2024 and includes an Activated Lymphatic onesie, $200, which Dovey maintains a patent for on the pattern and design, and Activated Lymphatic leggings, $149. According to Dovey, the Heat Healer collection has become a multimillion-dollar opportunity in just one year, and she expects Cean to reach similar sales in its first year. 'It went crazy. We've had so much good feedback about it. We've had just so many amazing stories from customers [on] how it's helped them,' Dovey said. From there, consumers wanted more. 'We had so much feedback that was like, 'Can you make a long sleeve? Why can't you make this with plant-based fibers? Why can't you make different colors?'' Dovey said. 'When we were launching it under Heat Healer, I had this dream of this very functional suit that looked really chic and you could pair it with different clothing. Having it become its own line didn't really make sense under the Heat Healer brand.' Therefore Dovey set out to create Cean as a separate brand, implementing all of the feedback from consumers — most notably that there would be an array of styles that could range from activewear to loungewear; an array of colors, and it would employ plant-based fibers. According to Dovey, the biggest challenge was creating something that featured medical-grade compression and used plant-based fibers — in the realm of activewear, plant-based fibers have become increasingly popular again, as more consumers are concerned with the toxins that could be released from typical fitness fabrics like polyester. 'Our skin is our biggest organ, and having something close to your skin when you're sweating or moving, it's just really important to consider what you're putting on it,' Dovey said. She worked closely with a manufacturer to develop something that met her and her consumers' standards. The brand is manufactured and warehoused in Los Angeles. 'The fiber is 70 percent MicroModal, which is actually made from beech trees.…Comparing it to the Heat Healer pieces, it's got this bouncy really breathable feeling to it,' she said, noting that it does not feature the infrared yarn that the Heat Healer's offerings use, which supports temperature regulation, circulation and recovery. According to Dovey, to provide wearable lymphatic drainage, Cean's products employ medical-grade graduated compression and micromassage via light pressure points in the fabric. '[The compression] is like a pump that is tighter at the ankles or tighter at your wrists or tighter at your extremities, and then it's pushing the fluid toward your lymph nodes.…The second component is the micro massage,' she said. 'With those two things together, it's all basically lifting, supporting, sculpting, without restricting.' While Cean is launching with a variety of designs, Dovey has more in mind, including seasonal capsules. 'The sky is the limit with the pieces,' she said.
Yahoo
an hour ago
- Yahoo
At-home health tests have surged in popularity. But many are unclear and unreliable, UK report finds
A slew of at-home medical tests have flooded supermarkets, pharmacies, and wellness shops in recent years, claiming they can identify everything from gluten sensitivity to male fertility without the need for a doctor's visit. But most self-tests sold do not provide clear information about who should use them, how to interpret the results, or what to do next, according to a new pair . Many also contradict formal health guidance, which could be confusing and prompt people to make 'inappropriate' decisions about their health care, the researchers warned. 'We expect [a self-test] to be accurate and we expect it to be evidence-based if it's going to be sold to the general public,' Dr Alex Richter, one of the studies' authors and a professor of clinical immunology at the University of Birmingham, said during a press briefing. 'Unfortunately, we found that many tests gave unclear or at least missing guidance'. Related Promising results show new spit test could be better at detecting prostate cancer than blood test Independent experts said the results were alarming, particularly given the booming market for at-home tests, predicted to be valued at hundreds of millions of euros by 2030. But with the abundance of choice, it can be difficult for consumers to pick out high-quality tests from the pack. For the new reports, Richter's team examined 30 self-tests for 19 health issues, including vitamin D deficiency, menopause, blood sugar levels, HIV, bowel cancer, and prostate health. Only 14 tests made statements about their accuracy, eight offered information on the box about who should or should not use the test, and seven told consumers what they should do after taking the test. Sixteen tests explicitly said they were for screening, diagnosis, or monitoring, while another nine did not provide information about the symptoms or risk factors for their use. Nearly all of the tests recommended following up with a doctor if the results were positive or abnormal, the studies found. Two dozen tests claimed they were highly accurate, but the evidence to back up those assertions was either of poor quality or not publicly available, prompting the researchers to raise ethical concerns. Two companies – Newfoundland and Suresign – had the most problematic tests, the research found. They make rapid tests for menopause, vitamin D deficiency, the diagnosis of chronic kidney injury, and to detect thyroid problems. Independent experts said the results should serve as a reminder that at-home tests can be useful, but they should not replace traditional, evidence-based medical care. Related Exclusive: At-home spit test that measures hormone levels is now certified as a contraceptive 'Sometimes people use self-tests because they 'feel it is better to know' and they are trying to inform their health and healthcare decisions,' Dr Amitava Banerjee, a cardiologist and professor of clinical data science at University College London, said in a statement. 'This research shows that these self-tests are often not providing relevant knowledge or information and they are not informing decisions in the right way,' added Banerjee, who was not involved with the studies. The study authors called for more regulation of self-tests, saying they should be thoroughly evaluated before reaching the supermarket or pharmacy shelves to protect consumers and the healthcare system from 'misuse and misinformation'. Richter said the findings should not cause people to cast doubt on all self-tests. At-home pregnancy tests, for example, have been available for many years and are highly reliable when used correctly. And during the COVID-19 pandemic, self-tests were a cheaper, faster way for people to identify infections, easing some of the burden on the health system. 'We think there is a real place for this. … We just need to work out how they can be properly used and assessed,' Richter said. 'We don't want bad tests on the market, we want good tests on the market'.
Medscape
an hour ago
- Medscape
Taurine: From Energy Drink Darling to Cancer Suspect?
Taurine enjoys a strong reputation for boosting both physical and mental performance and has long been a staple ingredient in many energy drinks. A 2023 study in Science even suggested that supplementing this amino sulfonic acid — which the body can produce endogenously — could extend life span, at least in mice and monkeys. That research, led by Parminder Singh, PhD, of the Buck Institute in Novato, California, also observed that taurine levels in human blood appear to decline with age. These findings helped fuel a rise in over-the-counter taurine supplement sales. But new evidence suggests that the antiaging effects may be overstated — and that high intake of taurine could even pose risks, including a possible increase in blood cancer susceptibility for some individuals. Poor Fit as Aging Biomarker A more recent Science study casts further doubt on taurine's longevity promise. Maria Emilia Fernandez, PhD, and colleagues at the National Institute on Aging, Baltimore, found that taurine does not serve as a reliable biomarker of biological aging. Unlike the earlier cross-sectional study, their longitudinal research repeatedly measured taurine levels in participants over time. The results showed no consistent age-related decline. In many cases, taurine concentrations increased with age. The researchers concluded that individual variability far outweighed any patterns linked to aging. No Reliable Reference Ranges 'There are no reliable reference values for taurine that could be applied broadly to the general population,' Kristina Norman, MD, head of the Department of Nutrition and Gerontology at the German Institute of Human Nutrition in Potsdam-Rehbrücke, Nuthetal, Germany, told Medscape's German edition . Still, she noted that the study doesn't rule out the possibility that taurine may have beneficial effects in specific contexts — such as for cardiometabolic health. 'That was not the question Fernandez and her colleagues set out to explore,' said Norman, who is also the deputy director of the Research Group in Geriatrics at the Charite Universitätsmedizin Berlin, Berlin, Germany. 'There are a number of interventional studies on taurine supplementation,' Norman added, 'but the results have been inconsistent, which makes interpretation difficult.' Currently, the effects of taurine appear highly dependent on individual factors, including a person's age and underlying health status. As such, Norman advised that taurine supplementation should neither be broadly recommended nor discouraged at this stage. Taurine in the Diet — and in the Data According to the European Food Safety Authority, the maximum safe daily intake of taurine is 100 mg/kg of body weight — about 7 g for a 70-kg adult. European regulations limit taurine in energy drinks to no more than 4 g/L. Taurine also occurs naturally as a breakdown product of the amino acids cysteine and methionine, particularly in meat, fish, seafood, and dairy products. Fernandez's study analyzed data from three human cohorts (973 participants in total) as well as blood samples from rhesus monkeys and mice. The researchers found no evidence of age-related declines in circulating taurine levels among healthy individuals — in fact, levels were often stable or increased with age. Diet, rather than age, showed a stronger correlation with taurine concentrations. Moreover, they found no association between taurine levels and physical parameters such as muscle strength or body weight. 'These findings challenge the prevailing hypothesis that taurine declines with age and contributes to aging,' Norman said. Linked With Leukemia Cell Growth A second study, recently published in Nature , has raised new concerns about potential risks associated with high taurine intake. Researchers led by Sonali Sharma, PhD, from the Department of Biomedical Genetics at the Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, found elevated taurine concentrations in the microenvironment of leukemia cells. They also identified taurine transporters on the cell membranes, which facilitated the uptake of taurine into the cells, where it appeared to support glycolysis. According to Sharma's team, taurine may play a role in both the development and progression of leukemia. 'It's still unclear whether this potential risk applies broadly or only to certain individuals — such as those with a personal or family history of blood cancer,' said Norman. She also noted that it remains uncertain whether orally supplemented taurine even reaches the tumor microenvironment. Nevertheless, she added, the findings open up new therapeutic possibilities — namely, targeting taurine transporters in malignant cells as a novel approach to leukemia treatment. Benefit for Longevity or Performance The Nature study also reinforces the need to re-evaluate taurine's use as a dietary supplement. 'Individuals at increased risk of leukemia should probably avoid taurine supplementation,' Norman advised. More broadly, she noted there is currently no strong evidence to support taurine's use for enhancing physical or cognitive performance or slowing the aging process. 'We simply don't have high-quality data confirming whether taurine works — or at what dose,' Norman said. She also cautioned that taurine's side-effect profile remains poorly understood. 'Taurine could potentially offer benefits in some clinical contexts,' she acknowledged. 'But right now, I would discourage people from taking it on their own 'just in case.''
